Other at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherSundryLiabilitiesCurrent.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s other?
- The Oncology Institute, Inc. (TOI) reported other of $5.67M in Q1 2026.
- How has The Oncology Institute, Inc.'s other changed year-over-year?
- The Oncology Institute, Inc.'s other decreased by 25.7% year-over-year, from $7.63M to $5.67M.
- What is the long-term trend for The Oncology Institute, Inc.'s other?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s other has grown at a 9.7% compound annual growth rate (CAGR), from $2.97M to $4.31M.